These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7483686

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES.
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R.
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD.
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V, Michael S, Prego V.
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH.
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
    Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, Tarara JE, Kephart GM, Kita H, Gleich GJ.
    Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ursodeoxycholic acid therapy in biliary cirrhosis].
    Herszényi L, Szalay L, Schaff Z, Gergely P, Fehér J.
    Orv Hetil; 1993 Sep 19; 134(38):2085-9. PubMed ID: 8414454
    [Abstract] [Full Text] [Related]

  • 19. Dipeptidyl peptidase IV in human T-lymphocytes: cytochemical and histochemical investigations in patients with non-Hodgkin's lymphoma.
    Schön E, Essbach U, Machura R, Franke A, Ansorge S.
    Acta Histochem Suppl; 1986 Sep 19; 33():131-8. PubMed ID: 2874587
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.